These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35935626)

  • 1. The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium.
    Zhang W; Li QQ; Gao HY; Wang YC; Cheng M; Wang YX
    Front Cardiovasc Med; 2022; 9():925254. PubMed ID: 35935626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension.
    Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS
    Front Physiol; 2021; 12():732084. PubMed ID: 34650444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases.
    Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y
    Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis.
    Islam R; Hong Z
    Mechanobiol Med; 2024 Dec; 2(4):. PubMed ID: 39281415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.
    Wang XL; Xian Y; Chen XL
    Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying the Geroprotective Properties of YAP/TAZ Signaling Inhibitors on
    Golubev DA; Zemskaya NV; Gorbunova AA; Kukuman DV; Moskalev A; Shaposhnikov MV
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Keloid Formation and YAP/TAZ Signaling.
    Aramaki-Hattori N; Okabe K; Hamada M; Takato T; Kishi K
    Plast Reconstr Surg Glob Open; 2017 Jun; 5(6):e1357. PubMed ID: 28740772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Perspectives of YAP/TAZ in Human Skin Epidermal and Dermal Aging.
    Kim JY; Quan T
    Ann Dermatol; 2024 Jun; 36(3):135-144. PubMed ID: 38816974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
    Deng F; Wu Z; Zou F; Wang S; Wang X
    Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.
    Kegelman CD; Collins JM; Nijsure MP; Eastburn EA; Boerckel JD
    Curr Osteoporos Rep; 2020 Oct; 18(5):526-540. PubMed ID: 32712794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
    Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
    Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of Exercise in Regulating YAP and TAZ During Cardiomyocytes Aging.
    Limyati Y; Sanjaya A; Lucretia T; Gunadi JW; Biben V; Jasaputra DK; Lesmana R
    Curr Cardiol Rev; 2022; 18(5):24-33. PubMed ID: 35379136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.